小分子向蛋白质降解通过UPS:冒险超越E3基质受体
Renyu Guo1, Fukang Yang1, Emily C Cherney1
1Discovery & Development Sciences, Bristol Myers Squibb Co Princeton New Jersey 08543 USA emily.cherney@bms.com.
RSC medicinal chemistry
|February 14, 2025
概括
小分子正在劫持无处不在蛋白质酶系统 (UPS) 来降解蛋白质. 新的策略针对E3结合酶以外的蛋白质,显示了新型向蛋白质降解 (TPD) 的前景.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 无素蛋白酶体系统 (UPS) 是蛋白质降解的关键细胞机械.
- 使用小分子的向蛋白质降解 (TPD) 已成为一种强大的治疗策略.
- 目前的TPD方法主要集中在招募蛋白质到E3无素连接酶.
研究的目的:
- 审查小分子介导TPD的新兴策略.
- 探索超越E3结合酶基质受体的UPS组件的合作选择.
- 突出这些新型TPD方法的潜在优势.
主要方法:
- 关于小分子诱导蛋白质降解的最新科学文献的综述.
- 对针对各种UPS组件的研究进行分析,包括E2酶,适配器,伴侣和蛋白酶子单元.
- 讨论这些新型TPD策略的机制和潜力.
主要成果:
- 小分子可以通过准各种蛋白质成分,有效地劫持UPS.
- 除了E3酶招募之外的方法正在显示出显著的前景.
- 这些新兴策略比传统的TPD方法具有潜在的优势.
结论:
- 在UPS中扩展TPD目标,超越E3结合酶,开辟了新的治疗途径.
- 这些新的方法代表了快速发展的药物发现前沿.
- 对这些策略的进一步研究可能会导致对以前无法治疗的目标进行治疗.
相关概念视频
Regulated Protein Degradation
7.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
The Proteasome
801
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
801
The Proteasome Structure
677
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
677
Export of Misfolded Proteins out of the ER
3.4K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.4K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
The Unfolded Protein Response
4.4K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K


